Caroline Popper M. D.

About Caroline Popper M. D.

Healthcare has entered a phase of dramatic change driven by data science, new biological insights, resource constraint.and the rise of the consumer. I approach these opportunities and challenges from a legal, business and clinical background. I am a member of the Maryland Bar.Nemphos Braue is a Mid-Atlantic boutique law firm, focused on helping clients succeed, one relationship at a time. Nemphos Braue specializes in corporate law, business law, start-up law, entrepreneurial law and mergers & acquisitions. The NB team approach provides clients with creative and effective legal solutions across all disciplines and offers the best results to manage clients’ legal and business objectives.Popper and Company is a strategy and M&A advisory firm. Our mission is Deliberate Acceleration. This means we apply rigorous, independent thinking and our rare blend of business, clinical, and scientific expertise to drive innovative, meaningful change – we seek to work with clients who are committed to disrupting the status quo and who challenge us to be our best.Popper and Company takes a comprehensive approach to helping our clients leverage information to improve healthcare. We’re made up of a team of diverse professionals – physician entrepreneurs across multiple disciplines, clinicians, engineers, marketers and scientists – each with a unique perspective and problem-solving capabilities. At Popper, we deliver the best thinking possible, presented in new and different ways to enable and accelerate the growth of your company.SpecialtiesHealthcare law, M&A, licensing, regulatory strategy, agreement structuring & negotiation, corporate strategy development, product commercialization, cost-in-use analysis, diagnostics, strategic partnering, digital health, wellness, life science, medical & wireless health technologies, companion diagnostics and companion devices. re-imagining healthcare delivery

Experience

1. Director, Board Member

   cmbio

   May 2023 — Present · DK

Education

• American University Washington College of Law

  JD (cum laude)

• Johns Hopkins Bloomberg School of Public Health

  Master of Public Health - MPH

• The Johns Hopkins University

  MPH, Health Policy and Health Economics

  1989 — 1990

• University of the Witwatersrand

  MBBCh (MD)

Skills

• Management
• Clinical Trials
• Molecular Biology
• Strategic Partnerships
• U.s. Food and Drug Administration (Fda)
• Medicine
• R&D
• Technology Evaluation
• Protein Chemistry
• Mergers & Acquisitions
• Clinical
• Diagnostics
• Commercialization
• Venture Capital
• Cell Biology
• Validation
• Science
• Biochemistry
• Cell
• Biotechnology
• Research and Development (R&D)
• Mergers
• Start-Ups
• Immunology
• Drug Discovery
• Strategic Planning
• Life Sciences
• Infectious Diseases
• Marketing Strategy
• Medical Devices
• Clinical Research
• Medical Diagnostics
• Clinical Development
• Drug Development
• Pharmaceutical Industry
• Fda
• Cancer
• Biopharmaceuticals
• Lifesciences
• Strategy